Literature DB >> 29094333

Unnoticed maternal Graves' disease revealed by the baby's low free thyroxine in newborn screening: an underestimated condition supporting thyroid disease screening among pregnant women.

M Adachi1, A Soneda2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29094333     DOI: 10.1007/s40618-017-0777-9

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  5 in total

1.  Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed.

Authors:  Marlies J E Kempers; David A van Tijn; A S Paul van Trotsenburg; Jan J M de Vijlder; Brenda M Wiedijk; Thomas Vulsma
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

2.  Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women.

Authors:  Chrysoula Dosiou; James Barnes; Alan Schwartz; Roberto Negro; Lawrence Crapo; Alex Stagnaro-Green
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

Review 3.  Neonatal hypothyroxinemia with normal thyrotropin. Clue to maternal Graves' disease.

Authors:  A H Slyper; J L Shaker
Journal:  Clin Pediatr (Phila)       Date:  1993-02       Impact factor: 1.168

4.  Hyperthyroidism incidence fluctuates widely in and around pregnancy and is at variance with some other autoimmune diseases: a Danish population-based study.

Authors:  Stine Linding Andersen; Jørn Olsen; Allan Carlé; Peter Laurberg
Journal:  J Clin Endocrinol Metab       Date:  2014-12-08       Impact factor: 5.958

5.  Overall usefulness of newborn screening for congenital hypothyroidism by using free thyroxine measurement.

Authors:  Akiko Soneda; Masanori Adachi; Koji Muroya; Yumi Asakura; Yuji Yamagami; Fumiki Hirahara
Journal:  Endocr J       Date:  2014-08-02       Impact factor: 2.349

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.